United States· US:0006-3069_20dc2455-4d48-4183-b1ad-29a2686dcd2a
PIFELTRO
A doravirine product containing doravirine, registered in United States by Merck Sharp & Dohme LLC. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Doravirine is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AG06 (doravirine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Doravirine · ATC J05AG06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of doravirine costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $8.24 in France to $16.15 in Switzerland — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Doravirine · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$16.15
- FR France$8.24
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DORAVIRINE
- Manufacturer
- Merck Sharp & Dohme LLC
- Country
- United States (US)
- ATC code
- J05AG06
- ATC class
- Doravirine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 12, 2026
Packs & prices · 2
- ndc110006-3069-01
- ndc11000630690130 TABLET, FILM COATED in 1 BOTTLE (0006-3069-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
88 interactions on record for doravirine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doravirine · interactions on record
88 records
- 9 severe
- 22 moderate
- 57 minor
Most severe, free to view
- DexamethasoneH02AB02severe
- DabrafenibL01EC02severe
- LorlatinibL01ED05severe
- DabrafenibL01XE23severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doravirine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandPifeltroMerck Sharp & Dohme B.V.
- NorwayPifeltroAbacus Medicine A/S
- CzechiaPIFELTROMerck Sharp & Dohme B.V., Haarlem
- BelgiumPifeltro 100 mgMerck Sharp & Dohme
- IcelandPifeltroMerck Sharp & Dohme B.V.*
- NetherlandsPifeltro 100 mg filmomhulde tablettenMerck Sharp & Dohme B.V.
- PolandPifeltroMerck Sharp & Dohme B.V.
- SwedenPIFELTRO 100 mg Filmdragerad tablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pifeltro
- Liechtenstein · Pifeltro
- Norway · Pifeltro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3eff9e48-917a-41da-87b2-a844be0af340 GET /v1/drugs/3eff9e48-917a-41da-87b2-a844be0af340?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "DORAVIRINE",
"productndc": "0006-3069",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA210806",
"marketing_category": "NDA"
}See everything about doravirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.